Carna Biosciences Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	6,293	6,814	5,729	8,950	7,390	14,666
Market Cap Growth	13.24%	18.93%	-35.99%	21.11%	-49.61%	-2.43%
Enterprise Value	6,491	6,354	3,506	5,737	3,994	11,150
Last Close Price	328.00	356.00	300.00	522.00	520.00	1102.00
PS Ratio	10.87	11.77	9.01	5.51	5.33	7.27
PB Ratio	20.35	22.04	2.32	2.31	2.03	3.40
P/TBV Ratio	20.35	22.04	2.32	2.31	2.03	3.40
EV/Sales Ratio	11.21	10.97	5.51	3.53	2.88	5.53
EV/FCF Ratio	-2.99	-	-	-	-	-
Debt / Equity Ratio	2.31	2.31	0.02	0.05	0.08	0.13
Net Debt / Equity Ratio	0.64	0.64	-0.83	-0.70	-0.85	-0.76
Net Debt / EBITDA Ratio	-0.10	-0.10	1.00	2.50	2.49	6.40
Net Debt / FCF Ratio	-0.09	-0.09	1.48	1.60	3.69	2.08
Asset Turnover	0.29	0.29	0.18	0.38	0.29	0.39
Inventory Turnover	1.24	1.24	1.16	1.36	1.50	1.26
Quick Ratio	3.67	3.67	9.89	9.81	8.17	6.54
Current Ratio	6.99	6.99	12.33	11.18	9.41	6.87
Return on Equity (ROE)	-155.96%	-155.96%	-68.60%	-30.65%	-33.92%	-13.13%
Return on Assets (ROA)	-64.81%	-64.81%	-36.44%	-16.21%	-16.37%	-6.46%
Return on Invested Capital (ROIC)	-455.56%	-445.31%	-260.48%	-129.21%	-159.25%	-107.49%
Return on Capital Employed (ROCE)	-195.50%	-195.50%	-81.40%	-28.10%	-33.20%	-11.40%
Earnings Yield	-34.51%	-31.87%	-38.02%	-12.87%	-18.25%	-3.64%
FCF Yield	-34.46%	-31.83%	-24.21%	-18.86%	-11.29%	-10.75%
Buyback Yield / Dilution	-6.71%	-6.71%	-6.61%	-23.37%	-7.26%	-3.22%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.